Intelligence Ventures

AGED Diagnostics delivers noninvasive blood tests that diagnose MASH and stage liver fibrosis across the full spectrum of disease—supporting better clinical decisions and proactive disease management.

Building the future of brain-computer interfaces, non-invasively, that allows people to control next generation of AI-powered prosthetics and robotics.

Xander designs simple, wearable assistive technology to simplify communication, enhance understanding, restore confidence, and empower people with hearing challenges in daily conversations.

Elnora AI is a domain name for sale, offering premium verified domain services with secure payment options.

UBiosis Health provides UBi, an AI-powered nurse designed to improve outcomes for patients with inflammatory bowel disease (IBD) by monitoring biomarkers and facilitating patient engagement without disrupting existing clinical workflows.

HEARTio is an AI-powered diagnostic platform that diagnoses heart disease using a simple ECG, empowering providers to prevent heart attacks before they strike.

Atapir is developing a non-contact, remote monitor to reduce the risk of respiratory and cardiac arrest in hospitalized and nursing home patients. This monitor measures heart rate, respiratory rate, pulse oximetry, perfusion, pain, mood, and other parameters remotely and scans for life.

Directed Systems is a medical software and data science company focused on developing advanced solutions to improve patient outcomes in hospital and emergency care through data-driven insights and physiological modeling.

MDC is focused on improving cancer diagnosis and treatment with a novel robotic system.

Friále is a solo-GP venture capital fund headquartered across San Francisco and Nashville that backs early-stage startups globally, with a notably strong presence in Africa and India despite being a small fund. The fund focuses on AI and healthcare companies while consistently co-investing alongside top-tier firms like Andreessen Horowitz and Y Combinator, positioning itself as a high-signal collaborative partner rather than trying to lead rounds.

Early-stage investor spanning service-heavy care delivery and deep neuro/bio/AR frontier tech. Arkitekt Ventures deliberately spans both service-heavy care delivery companies and deep frontier neuro/bio/AR technologies, reflecting a thesis that the future of care sits at the intersection of physical clinics and bleeding-edge tech. The fund shows an unusually high concentration in brain- and nervous-system related innovation, suggesting a distinctive neuro + AI + delivery wedge inside healthtech.

Micro-stage bridge fund for India and Southeast Asia with 2–3-call lightweight diligence that moves faster and connects founders to a curated network of Silicon Valley operators who have built unicorns. Backed by top global founders like Naval Ravikant and founders of Xiaomi, Thumbtack, and other unicorns.

AI-only fund focused on explainable AI, operating as an evergreen recycling exits, co-founded by Venkat Srinivasan—AI scientist, serial founder with multiple AI-driven exits—and strong MIT/Harvard sourcing ties. Innospark Ventures is an AI-only venture fund that exclusively backs startups where AI is the core of the business. The fund operates as an evergreen structure that recycles exits back into the same-sized pool to build a long-term legacy fund, while focusing on explainable AI systems and maintaining deep ties to East Coast research institutions like MIT and Harvard for sourcing deals.

Seed-stage VC focused on investing in companies that make meaningful advancements to patient care.